Sofinnova Partners SAS

Holdings History for Quince Therapeutics, Inc. - Common Stock, par value $0.001 per share (QNCX)

Symbol: QNCX on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.001 per share
Latest Disclosed Ownership: 2.4M shares
Security Ownership: 5.4%

Sofinnova Capital VIII ownership in Quince Therapeutics, Inc. Common Stock, par value $0.001 per share (QNCX)

2025-02-14 - Sofinnova Capital VIII has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.4M shares of Quince Therapeutics, Inc. Common Stock, par value $0.001 per share (QNCX). This represents 5.4% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Sofinnova Capital VIII	5.4%		$3.38M	2.4M			$1.41	13G	12/31/2024	14 Feb 2025 16:29:44